According to Vantage Market Research, the cancer diagnostics market is witnessing rapid growth driven by rising global cancer prevalence, advancements ...

A simple blood test could make asthma treatment more precise, more effective—and potentially more affordable. Researchers ...

WILMINGTON, DE, UNITED STATES, September 1, 2025 /EINPresswire.com/ -- Hospital Microbiology Testing Market is expected to grow from USD 6.00 billion in 2024 to USD 13.65 billion by 2032, at an ...

U.S. market entry set to begin for QIAstat-Dx Rise – a version of QIAstat-Dx for syndromic testing that combines unparalleled throughput with the easiest workflowQIAstat-Dx Rise launch can process up ...

ACU supports HEPA H13 and optional ULPA stages, delivering up to 99.999% particle removal efficiency at MPPS. This makes it suitable for occupational health protection, infection-risk reduction, and ...

Overview of the Esoteric Testing MarketThe global Esoteric Testing Market is valued at USD 30.56 Billion in 2024 and is projected to reach a value of USD 84.12 Billion by 2035 at a CAGR (Compound ...

The growing prevalence of multidrug-resistant bacteria (MDRB) presents a significant global health challenge, complicating infectious disease treatment and ...

Innovative cell membrane technologies and nanotechnology are transforming drug delivery and diagnostics, leveraging ...

Testing the molecular profile of tumours identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live ...

The global Still's disease treatment market is poised for significant growth driven by advancements in biologic therapies, increasing awareness, and early diagnosis enabled by improving healthcare ...